People Can Get Controlled Medications via Telehealth for Awhile Longer, DEA Says

By Kristen Rogers

The U.S. Drug Enforcement Administration (DEA) has provided a six-month extension for telehealth-prescribed controlled medications, such as stimulant medications for attention-deficit hyperactivity disorder, benzodiazepines for anxiety, or medications for opioid use disorder, sleep, or pain. The flexibilities that suspended prescription requirements that patients must have one in-person medical examination before receiving controlled substances for treatment were adopted during the COVID-19 public health emergency, which ends May 11. DEA Administrator Anne Milgram said, "We recognize the importance of telemedicine in providing Americans with access to needed medications, and we have decided to extend the current flexibilities for six months while we work to find a way forward to give Americans that access with appropriate safeguards."

Read more on CNN.